HealthDay News — In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American Journal of Gastroenterology, recommendations are ...

Currently, coxib therapy is more expensive than combination therapy using a nonselective NSAID plus a PPI. Conclusions: Compared with combination therapy including a nonselective NSAID and PPI ...

Be sure to discuss the risks and benefits of prolonged PPI therapy with your healthcare provider for optimal safety. H2 ...

The authors conclude that gastric acid suppression induced by PPIs, but not by H 2 RAs, is associated with an increased risk of salmonella and campylobacter enteric infections. They suggest that ...

A previous guideline was published in 2017. It had maintained the recommendation of a proton pump inhibitor-clarithromycin ...

Use the lowest dose of Protonix and for the shortest duration of PPI therapy appropriate to the condition. PPI therapy may be associated with a greater risk of osteoporosis-related fractures of ...

Proton-pump inhibitors like pantoprazole are often used in people after surgical treatment for esophageal cancer. They reduce ...

In Table 5, we attempted to distill the numerous issues into a single table to aid in choosing between a coxib versus a combination of nonselective NSAID plus PPI therapy for the treatment of ...

Dupilumab is suggested for individuals aged 12 years or older and for pediatric patients who are nonresponsive to PPI therapy. Omalizumab is not suggested for EoE treatment. For esophageal ...